Cerebral Ischemic Reperfusion Injury
Tech ID
P35-1355
Patent Status
Granted in India
Design Status
--
Technical Description
The present invention relates to a parenteral or an intravenous micro suspension of barium containing bioactive glass for treating cerebral ischemic reperfusion injury.
Problems Addressed
- High Toxicity
- Ischemic Stroke Damage
- Platelet Cohesion
- Thrombin Production
- Increased Formulation Strength Required
- Limited Efficiency of Existing Treatments
TARGET AUDIENCE
- Medical and Healthcare Sector
- Pharmaceutical Industry
- Medical Device Manufacturing Industry
- Public Health Sector
- Research & Development
TECH FEATURES
- Low Toxicity
- Anti-Thrombotic Properties
- Negligible Hemolytic Activity
- Cerebral Ischemic Reperfusion Treatment
- Anti-Platelet Activities
- Therapeutic Applications
P35-1355
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com